Skip to content

Facebook Support Groups for Pediatric Rare Diseases: Cross-Sectional Study to Investigate Opportunities, Limitations, and Privacy Concerns

Facebook Support Groups for Pediatric Rare Diseases: Cross-Sectional Study to Investigate Opportunities, Limitations, and Privacy Concerns

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016067
Enrollment
100
Registered
2019-05-29
Start date
2019-07-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rare diseases with childhood onset

Interventions

Group 1: Using an online questionnaire, members of Facebook support groups for rare diseases with childhood manifestation answer questions about usage, (dis-)advantages and concerns regarding the use

Sponsors

Institut für Humangenetik, Universität Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The test persons are members of Facebook groups with the following inclusion criteria: Topic of the Facebook group is a rare disease with childhood manifestation. These rare diseases are listed in the database Orphanet as disease with age of onset antenatal, conatal/neonatal, infancy, childhood or adolescent. The inclusion criteria are tested with questionnaire item 1.1 „Are you part of a Facebook support group for a rare disease?“, answer must be „yes“.

Exclusion criteria

Exclusion criteria: Exclusion criterion is the reponse „no“ to questionnaire item 1.1 „Are you part of a Facebook support group for a rare disease?“

Design outcomes

Primary

MeasureTime frame
The primary outcome is an overview of usage of the social network „Facebook“ as a tool for online support groups for rare diseases with childhood manifestation. This will be evaluated in 2019 using an online questionnaire.

Secondary

MeasureTime frame
The secondary outcome is to analyse the group members’ view on opportunities, limitations, and privacy concerns regarding the use oft he social network „Facebook“ as a medium for support groups for rare diseases with childhood manifestation.

Countries

Germany

Contacts

Public ContactChristian Schaaf

Institut für Humangenetik, Universität Heidelberg

schaaf@bcm.edu06221-56-5151

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 14, 2026